Donor immune cells target deadly EBV lymphoma in single-patient trial
NCT ID NCT06391814
First seen Mar 27, 2026 · Last updated May 19, 2026 · Updated 7 times
Summary
This study tested a treatment for one young adult with a severe EBV-related lymphoma after a stem cell transplant. Doctors took immune cells from the donor, trained them to attack the Epstein-Barr virus, and gave them to the patient. The main goal was to see if this approach was safe and did not cause graft-versus-host disease, while also checking if it helped control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBV ASSOCIATED LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ciusss-Emtl
Montreal, Quebec, H1T 2M4, Canada
Conditions
Explore the condition pages connected to this study.